Clinical Trials Browser

Adenocarcinoma × motexafin gadolinium × Thoracic × Clear all

NCT00129844 2008-08-20

Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer

Phase 2 Completed

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms